Table 3. Prevalence of arboviruses and other infectious causes of rash and co-infections in patients treated at FMT-HVD, Manaus, between February 2018 to May 2019.
| Monoinfections (N = 340) | n (%) |
|---|---|
| ZIKV | 222 (65.3) |
| DENV | 3 (0.9) |
| CHIKV | 1 (0.3) |
| Parvovirus B19 | 3 (0.9) |
| Measles | 10 (2.9) |
| HIV | 1 (0.3) |
| Syphilis | 2 (0.6) |
| Co-infections | |
| ZIKV + HIV | 1 (0.3) |
| ZIKV + Measles | 1 (0.3) |
| ZIKV + Parvovirus B19 | 1 (0.3) |
| ZIKV + EBV | 1 (0.3) |
| EBV + Parvovirus B19 | 1 (0.3) |
| CMV + Parvovirus B19 | 2 (0.6) |
| CMV + Syphilis | 1 (0.3) |
| ZIKV + EBV + Parvovirus B19 | 1 (0.3) |
| CMV + EBV + Parvovirus B19 | 3 (1.2) |
| Negative for all infections tested | 86 (25.3) |
EBV: Epstein-Barr; CHIKV: Chikungunya virus; CMV: Cytomegalovirus; DENV: Dengue virus; HIV: Human Immunodeficiency Virus; ZIKV: Zika virus.